Prussian blue-based intelligent pH-triggered MRI drug release-monitoring synergetic nanometer diagnosis and treatment agent and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN ยท China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SHANGHAI INST OF CERAMIC CHEM & TECH CHINESE ACAD OF SCI
- Publication Date
- 2015-11-11
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of nanomaterials and the field of biomedical materials, in particular to a nano-diagnostic and therapeutic agent based on hollow mesoporous Prussian blue pH-responsive nuclear magnetic resonance imaging (MRI) and photoacoustic imaging under the guidance of dual modes of hyperthermia and chemotherapy for synergistic treatment of tumors and its preparation method. Background technique
[0002] Magnetic resonance imaging is a non-invasive imaging method with high resolution and the ability to obtain anatomical and physiological information. It is widely used in the field of diagnosis and treatment. Currently in clinical practice, T 1 weighted contrast ratio T 2 Weighted contrast agents have more advantages, such as it is difficult to distinguish some dark spots due to T 2 The effect of the contrast agent is still caused by blood calcification, metal deposition, or some other background signals. Currently us...